Bupivacaine 2.5 mg/ml Solution for Injection
*Company:
Baxter Holding B.V.Status:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 02 April 2024
File name
ie_spc_Bupivacaine-2.5mg_PA2299-035-001_Jan 2024.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.7 - Effects on ability to drive and use machines
- Change to section 4.8 - Undesirable effects
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 02 August 2023
File name
1400008372_Bupivacaine 2.5 & 5_UK_IE_Approved.pdf
Reasons for updating
- New PIL for new product
Updated on 23 January 2023
File name
ie-spc-2019-07-Bupivacaine-2.5mg-english-var021-c.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 09 June 2020
File name
ie-spc-2019-07-Bupivacaine-2.5mg-english-var021-c.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)